VERU INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- VERU INC. payments for repurchase of common stock for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- VERU INC. payments for repurchase of common stock for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- VERU INC. payments for repurchase of common stock for the quarter ending 2014-09-30 was $519.91K, a 2096.05% increase year-over-year.
- VERU INC. payments for repurchase of common stock for the quarter ending 2014-06-30 was $207.47K.
- VERU INC. payments for repurchase of common stock for fiscal 2015 was $950.00, a 99.87% decline from fiscal 2014.
- VERU INC. payments for repurchase of common stock for fiscal 2014 was $737.75K, a 86.46% increase from fiscal 2013.
- VERU INC. payments for repurchase of common stock for fiscal 2013 was $395.67K, a 36.62% increase from fiscal 2012.
- VERU INC. payments for repurchase of common stock for fiscal 2012 was $289.61K, a 775.94% increase from fiscal 2011.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $950.00 10-K · filed 2018-01-02 |
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-07-28 | |
| 2014-09-30 | $519.91K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $737.75K 10-K · filed 2016-12-12 |
| 2014-06-30 | $207.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-30 | |
| 2013-09-30 | $23.68K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02 | $395.67K 10-K · filed 2015-12-02 |
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-31 | $602.60K derived: sum of 4 quarters · filed 2014-12-02 |
| 2013-03-31 | $193.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $656.91K derived: sum of 4 quarters · filed 2014-12-02 |
| 2012-12-31 | $178.00K 10-Q · filed 2014-02-03 | $462.92K derived: sum of 4 quarters · filed 2014-12-02 |
| 2012-09-30 | $230.61K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02 | $289.61K 10-K · filed 2014-12-02 |
| 2012-06-30 | $54.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01 | $59.00K derived: sum of 4 quarters · filed 2013-12-03 |
| 2012-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $4.69K derived: sum of 4 quarters · filed 2013-12-03 |
| 2011-12-31 | $4.69K 10-Q · filed 2013-01-30 | $4.69K derived: sum of 4 quarters · filed 2013-12-03 |
| 2011-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $33.06K 10-K · filed 2013-12-03 |
| 2011-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | $211.67K derived: sum of 4 quarters · filed 2012-12-04 |
| 2011-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-01 | |
| 2010-12-31 | $33.06K 10-Q · filed 2012-01-31 | |
| 2010-09-30 | $178.61K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $349.06K 10-K · filed 2012-12-04 |
| 2009-09-30 | $3.83M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |